- 1.
Malt UF, Malt EA, Blomhoff S, Refnin I. Funksjonelle somatiske lidelser – en oversikt Tidsskr Nor Lægeforen 2002; 122: 1379 – 84.
- 2.
Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354: 936 – 9.
- 3.
Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001; 134: 868 – 81.
- 4.
White KP, Speechley M, Harth M, Øsatbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. Scand J Rheumatol 2000; 29: 44–51.
- 5.
White PD, Thomas JM, Kangro HO, Bruce-Jones WDA, Amess J, Crawford DH et al. Predicitions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 2001; 358: 1946 – 54.
- 6.
Evengård B, Klimas N. Chronic fatigue syndrome: probable pathogenesis and possible treatments. Drugs 2002; 62: 2433 – 46.
- 7.
Baseman JB, Tully JG. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997; 3: 21 – 32.
- 8.
Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62: 1094 – 156.
- 9.
Vojdani A, Choppa PC, Tagle C, Andrin R, Samimi B, Lapp CW. Detection of mycoplasma genus and mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998; 22: 355 – 65.
- 10.
Choppa PC, Vojdani A, Tagle C, Andrin R, Magtoto L. Multiplex PCR for the detection of mycoplasma fermentans, m. hominis and m. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes 1998; 12: 301 – 8.
- 11.
Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18: 859 – 65.
- 12.
Nasralla MY, Haier J, Nicolson NL, Nicolson GL. Examination of mycoplasmas in blood of 565 chronic illness patients by polymerase chain reaction. Int J Med Biol Environ 2000; 28: 15 – 32.
- 13.
Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. High prevalence of mycoplasma infections among European chronic fatigue syndrome patients: examination of four mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 2002; 34: 209 – 14.
- 14.
Nicolson GL, Nicolson NL. Gulf War illnesses: complex medical, scientific and political paradox. Med Confl Surviv 1998; 14: 156 – 65.
- 15.
Escalante A, Fischbach M. Musculosceletal manifestations, pain, and quality of life in Persian Gulf War veterans referred for rheumatologic evaluation. J Rheumatol 1998; 25: 2228 – 35.
- 16.
Grady EP, Carpenter MT, Koenig CD, Older SA, Battafarano DF. Rheumatic findings in Gulf War veterans. Arch Intern Med 1998; 158: 367 – 71.
- 17.
Bourdette DN, McCauley LA, Barkhuizen A, Johnston W, Wynn M, Joos SK et al. Symptom factor analysis, clinical findings, and functional status in a population-based case control study of Gulf War unexplained illness. J Occup Environ Med 2001; 43: 1026 – 40.
- 18.
Nicolson GL, Nicolson NL. Diagnosis and treatment of mycoplasmal infections in Persian Gulf War illness – CFIDS patients. Int J Occup Med Immunol Tox 1996; 5: 69 – 78.
- 19.
Nicolson GL, Nasralla M, Haier J, Nicolson NL. Diagnosis and treatment of chronic mycoplasmal infections in fibromyalgia and chronic fatigue syndomes: relationship to Gulf War illness. Biomed Therapy 1998; 16: 266 – 71.
- 20.
Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ 2000; 320: 1363 – 7.
- 21.
Taylor-Robinson D, Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemoter 1997; 40: 622 – 30.
- 22.
Collins JF, Donta ST, Engel CC, Baseman JB, Dever LL, Taylor T et al. The antibiotic treatment trial of Gulf War veterans’ illnesses: issues, design, screening, and baseline characteristics. Control Clin Trials 2002; 23: 333 – 53.
- 23.
Wessely S, Chalder T, Hirsch S, Pawlikowska T, Wallace P, Wright DJ. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995; 345: 1333 – 8.
- 24.
Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003; 160: 221 – 36.
- 25.
White PD, Thomas JM, Amess J, Grover SA, Kangro HO, Clare AW. The existence of a fatigue syndrome after glandular fever. Psychol Med 1995; 25: 907 – 16.
- 26.
Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection: another infectious disease relationship. Arch Intern Med 1997; 157: 2497 – 500.
- 27.
White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998; 173: 475 – 81.
- 28.
Rea T, Russo J, Katon W, Ashley RL, Buchwald D. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Arch Intern Med 1999; 159: 865 – 70.
- 29.
Buchwald D, Rea TD, Katon WJ, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med 2000; 109: 531 – 7.
- 30.
Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116: 103 – 13.
- 31.
Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16: 179 – 91.
- 32.
Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 319: 1692 – 8.
- 33.
Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH et al. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function. Med Actual 2002; 38: 549 – 61.
- 34.
Kaufmann A, Muhlradt PF, Gemsa D, Sprenger H. Induction of cytokines and chemokines in human monocytes by mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun 1999; 67: 6303 – 8.
- 35.
Seya T, Matsumoto M. A lipoprotein family from mycoplasma fermantans confers host immune activation through toll-like receptor 2. Int J Biochem Cell Biol 2002; 34: 901 – 6.
- 36.
Into T, Nodasaka Y, Hasebe A, Okuzawa T, Nakamura J, Ohata N et al. Mycoplasmal lipoproteins induce toll-like receptor 2- and caspases-mediated cell death in lymphocytes and monocytes. Microbiol Immunol 2002; 46: 265 – 76.
- 37.
Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 2000; 29: 301 – 9.
- 38.
Endresen GK. Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes. Rheumatol Int 2003; 23: 211 – 5.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.